SFDA CEO Dr. Hisham S. Aljadhey Meets Key Stakeholders To Enhance Food And Drug Safety In Jeddah

Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), recently engaged with officials from various sectors, including food, drug, and medical devices, in the Western Region. This meeting took place at the Jeddah Chamber of Commerce and Industry (JCCI) headquarters on Monday. Mohammed Yousuf Naghi, Chairman of the JCCI Board of Directors, was also present.

The gathering aimed to boost collaboration and investment opportunities within the SFDA's domain. It provided a platform for private sector representatives to voice their observations and challenges. This feedback is crucial for the SFDA to enhance its services and improve quality standards.

Dr. Aljadhey stressed the importance of improving product quality in the market to ensure consumer safety. He highlighted SFDA's commitment to supporting investments by leveraging its capabilities while adhering to public health legislation. The discussions focused on fostering effective partnerships between SFDA and private entities.

The CEO emphasized that private sector involvement is vital for achieving public safety through strict adherence to quality standards and compliance with SFDA regulations. He reiterated the need for collaboration and joint initiatives to meet national objectives for food and drug safety.

Representatives from the private sector expressed their gratitude for participating in this meeting. They acknowledged its significance in promoting cooperation and collective efforts towards common goals. During the session, they posed questions, shared inquiries, and offered suggestions.

Dr. Aljadhey and other SFDA officials addressed these queries according to their areas of expertise. This interaction helped clarify various issues and fostered a better understanding between the parties involved.

Commitment to Public Health

Dr. Aljadhey underscored the necessity for self-regulation mechanisms within the private sector. This approach aligns with broader government efforts to enhance safety and quality standards across industries.

The meeting served as an opportunity for both sides to explore ways of improving cooperation further. By working together, they aim to achieve significant advancements in ensuring public health safety through stringent quality measures.

The discussions highlighted how essential it is for all stakeholders involved—public or private—to collaborate effectively towards achieving shared goals related to food and drug safety in Saudi Arabia.

With inputs from SPA